Lineage Cell Therapeutics Provides Update on Renevia® Commercialization Plans

Go back to Lineage Cell Therapeutics Provides Update on Renevia® Commercialization Plans
(NYSE: LCTX) Delayed: 1.35 +0.05 (3.85%)
Previous Close $1.30    52 Week High
Open $1.30    52 Week Low
Day High $1.37    P/E N/A 
Day Low $1.29    EPS
Volume 724,039       

(NYSE: LCTX) Delayed: 1.35 +0.05 (3.85%)
Previous Close $1.30    52 Week High
Open $1.30    52 Week Low
Day High $1.37    P/E N/A 
Day Low $1.29    EPS
Volume 724,039